Завершено
Фаза II
Беларусь
АМИСЕЛИМОД (MT-1303) · Salix Pharmaceuticals, Inc., an affiliate of Bausch Health
A Phase 2, Randomized, Double-Blinded, Placebo Controlled, Parallel Group Study Evaluating the Efficacy and Safety of Amiselimod (MT-1303) in Subjects With Mild to Moderate Ulcerative Colitis (UC)